The Neoadjuvant Model and Complete Pathologic Response in Breast Cancer: All or Nothing?
JAMA Oncol
.
2016 Jun 1;2(6):760-1.
doi: 10.1001/jamaoncol.2015.6509.
Authors
Veerle Bossuyt
1
,
Christos Hatzis
2
Affiliations
1
Department of Pathology, Yale School of Medicine, Yale University, New Haven, Connecticut.
2
Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut3Yale Cancer Center, New Haven, Connecticut.
PMID:
26914064
DOI:
10.1001/jamaoncol.2015.6509
No abstract available
MeSH terms
Breast Neoplasms / drug therapy*
Breast Neoplasms / genetics
Breast Neoplasms / immunology
Breast Neoplasms / pathology
Female
Humans
Neoadjuvant Therapy*
Treatment Outcome